KD Short, SV Rajkumar, D Larson, F Buadi… - Leukemia, 2011 - nature.com We studied 174 consecutive patients with relapsed refractory multiple myeloma (MM) enrolled on a phase II clinical trial of pomalidomide plus low-dose dexamethasone at Mayo Clinic. Extramedullary disease (EMD) was present at the time of trial entry in 7.5% (13 of 174 patients). The rate ... Related articles - All 3 versions
[HTML] from ispub.comJ Leibowitz, M Cohen, N Hashmi, N Mirza… - The Internet Journal of …, 2011 - ispub.com Extramedullary plasmacytoma (EMP) is a rare neoplasm of plasma cell origin, and is diagnosed when there is a focus of monoclonal plasma cells in the soft tissue in the absence of systemic disease. EMP is characterized as a plasma cell tumor, along with solitary plasmacytoma ... Related articles - Cached - All 3 versions
J Bladé, LC Fernández, L Rosiñol… - Journal of clinical …, 2011 - ncbi.nlm.nih.gov We provide an overview on soft-tissue extramedullary plasmacytomas (EMPs) in multiple myeloma (MM). We reviewed the incidence of EMPs in MM, myeloma bone marrow homing, possible mechanisms of extramedullary spread, and prognosis and response to therapy. The incidence of EMPs ...
S Sachdev, RL Dodd, SD Chang, SG Soltys… - …, 2011 - journals.lww.com Wolters Kluwer Health may email you for journal alerts and information, but is committed to maintaining your privacy and will not share your personal information without your express consent. For more information, please refer to our Privacy Policy. ... Skip Navigation Links Home > ... All 3 versions
[HTML] from ascopubs.orgHV Naina, D Levitt, M Vusirikala… - Journal of Clinical …, 2011 - jco.ascopubs.org A 25-year-old man presented in 2004 with extensive ecchymosis and lower extremity compartment syndrome requiring emergency surgery. At this time he was diagnosed with acute promyelocytic leukemia (APL). Conventional cytogenetic analysis of the bone marrow showed ... Related articles - All 4 versions
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
